Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000276100 is classified as a miscellaneous noncoding RNA, specifically "ST7 overlapping transcript 4 conserved region 3", annotated in RFAM (RF02189) as a conserved non-protein-coding RNA locus. There is no experimental or bioinformatic evidence indicating a role as a therapeutic target, and it does not code for a protein, receptor, enzyme, transporter, or other druggable target class. This entry is not a known therapeutic target, and it does not encode a protein. No canonical biological function, disease role, or interaction data is available. The name is correct for a noncoding RNA but inappropriate as a pharmacological target name. This is a noncoding RNA locus, not a therapeutic target, and has no conventional druggability or clinical relevance as such.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST7 overlapping transcript 4 conserved region 3 (ST7-OT4_3).